2-amino-5-phosphonovalerate has been researched along with Kidney Diseases in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, CC | 1 |
| Chien, CT | 1 |
| Wu, MH | 1 |
| Ma, MC | 1 |
| Chen, CF | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Kidney Diseases
| Article | Year |
|---|---|
NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys.
Topics: 2-Amino-5-phosphonovalerate; Animals; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Kidn | 2008 |